 | Up a level |
Journal Article
Broekaert, I. J., van Koningsbruggen-Rietschel, S. and Rietschel, E. (2014). Cystic Fibrosis as a Rare Cause of Apple Peel Syndrome. Klinische Padiatr., 226 (1). S. 44 - 47. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3824
Dinger, K., Schwind, R., Jentgen, V., Mohr, J., Hirani, D. V., Vohlen, C., Doetsch, J., Odenthal, M., van Koningsbruggen-Rietschel, S. and Alcazar, M. Alejandre (2018). Deficiency of TNF alpha Impairs Alveolar and Bronchial Development but Does Not Attenuate Asthma-Like Disease in Offspring of Obese Dams. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Fischer, J., van Koningsbruggen-Rietschel, S., Rietschel, E., Vehreschild, M. J. G. T., Wisplinghoff, H., Kroenke, M. and Hamprecht, A. (2014). Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients. J. Antimicrob. Chemother., 69 (6). S. 1533 - 1537. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091
Schwarz, C., Schulte-Hubbert, B., Bend, J., Abele-Horn, M., Baumann, I., Bremer, W., Brunsmann, F., Dieninghoff, D., Eickmeier, O., Ellemunter, H., Fischer, R., Grosse-Onnebrink, J., Hammermann, J., Hebestreit, H., Hogardt, M., Huegel, C., Hug, M., Illing, S., Jung, A., Kahl, B., Koitschev, A., Mahlberg, R., Mainz, J. G., Mattner, F., Mehl, A., Moeller, A., Muche-Borowski, C., Nuesslein, T., Puderbach, M., Renner, S., Rietschel, E., Ringshausen, F. C., Schmidt, S., Sedlacek, L., Sitter, H., Smaczny, C., Tuemmler, B., Vonberg, R., Wielpuetz, M. O., Wilkens, H., Wollschlaeger, B., Zerlik, J., Dueesberg, U. and van Koningsbruggen-Rietschel, S. (2018). CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa. Pneumologie, 72 (5). S. 347 - 393. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Thomassen, J. C., Koerner, R., Meyer, M., Striegel, A., Rietschel, E. and van Koningsbruggen-Rietschel, S. (2022). 6 months approval of Kaftrio in Germany - first experiences from real life of people with C. Klinische Padiatr., 234 (5). S. 339 - 340. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3824
Thomassen, J. C., Meyer, M., Hagmeyer, L., Striegel, A. K., Metz, F., Koerner, R., Rietschel, E. and van Koningsbruggen-Rietschel, S. . 6-month approval of Kaftrio (R) in Germany-First experiences from real life of people with CF. Mon.schr. Kinderheilkd.. NEW YORK: SPRINGER. ISSN 1433-0474
van Koningsbruggen-Rietschel, S., Heuer, H. E., Merkel, N., Posselt, H. G., Staab, D., Sieder, C., Ziegler, J., Krippner, F. and Rietschel, E. (2016). Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients. J. Antimicrob. Chemother., 71 (3). S. 711 - 718. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091
van Koningsbruggen-Rietschel, S. and Rietschel, E. (2017). Cystic fibrosis. Disease on the way to personalized therapy. Mon.schr. Kinderheilkd., 165 (8). S. 681 - 688. NEW YORK: SPRINGER. ISSN 1433-0474